S. Sonnleitner

Human seroprevalence against Borrelia burgdorferi sensu lato in two comparable regions of the eastern Alps is not correlated to vector infection rates.

C. Lass‐Flörl, E. Schmutzhard, G. Margos, 2015, Ticks and tick-borne diseases.

Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host

R. Horres, G. Almanzar, M. Prelog, 2022, Nature Communications.

Are Babesia a risk factor for blood products in an alpine area?

H. Schennach, M. Bednarska, G. Walder, 2014, Parasites & Vectors.

The mutational steps of SARS-CoV-2 to become like Omicron within seven months: the story of immune escape in an immunocompromised patient.

R. Horres, G. Almanzar, M. Prelog, 2022, medRxiv.

Spotted Fever Group – Rickettsiae in the Tyrols: Evidence by Seroepidemiology and PCR

C. Lass‐Flörl, H. Schennach, G. Walder, 2013, Zoonoses and public health.

Comparison of Pfizer/BioNTech BNT162b2 COVID-19 (Comirnaty) Vaccination Effects in Aged Adults with Special Consideration for the Effectiveness of the Three-Color iSpot in Assessing Immune Response

G. Walder, S. Sonnleitner, S. Sonnleitner, 2023, Journal of Biosciences and Medicines.

The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro

C. Sturmbauer, W. Posch, G. Walder, 2022, Virologica Sinica.

Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants

W. Posch, G. Walder, L. Knabl, 2023, Frontiers in Immunology.